PMID- 16845846 OWN - NLM STAT- MEDLINE DCOM- 20060801 LR - 20060718 IS - 0743-6661 (Print) IS - 0743-6661 (Linking) VI - 38 IP - 2 DP - 2006 TI - Aortic valve replacement and long-term prognosis. PG - 126-35 AB - OBJECTIVE: We assessed the long-term risk of mortality associated with mechanical and biological aortic valve replacement (AVR). METHODS: We reviewed articles published during the last decade, with emphasis on large series reporting mortality data and follow up of 5 years or longer. The latest editions of textbooks on cardiology and cardiac surgery were also reviewed. We used mortality analysis methodology, comparing the observed mortality in these series to the expected mortality calculated from country specific life tables, to calculate the risk of mortality expressed as the mortality ratio (MR), values above 100% traducing the excess risk of mortality compared to the general population. RESULTS: After AVR, the MR varied from 120% to 350% for mechanical valve prostheses, and from 100% to 300 for bioprosthetic valves according to age at surgery. MR above 400% was associated with an AVR before the age of 50 years. No significant difference in the MR over age 50 years was found between mechanical and biological AVR. Independent prognostic factors after AVR are age at surgery, New York Heart Association (NYHA) functional class at time of surgery, left ventricular ejection fraction (LVEF), atrial fibrillation, and type and severity of valvular lesion. CONCLUSION: No difference was found for excess mortality between mechanical and biological AVR. Under the age of 50 years, higher mortality was associated with both mechanical and bioprosthetic AVR. FAU - Naslafkih, Abdelouahed AU - Naslafkih A AD - Universite de Montreal, Insurance Medicine Program, CP 6128 Succ, Centre-ville, Montreal, QC, Canada H3C 3J7. FAU - Francois, Sestier AU - Francois S FAU - Fix, Jean-Marc AU - Fix JM FAU - Khoury, Abdelnour AU - Khoury A LA - eng PT - Journal Article PT - Review PL - United States TA - J Insur Med JT - Journal of insurance medicine (New York, N.Y.) JID - 8401468 MH - Aged MH - Aortic Valve/physiopathology/*surgery MH - Female MH - Heart Valve Prosthesis Implantation/*mortality MH - Humans MH - Male MH - Middle Aged MH - Prognosis MH - *Risk Adjustment MH - Survivors MH - United States/epidemiology RF - 45 EDAT- 2006/07/19 09:00 MHDA- 2006/08/02 09:00 CRDT- 2006/07/19 09:00 PHST- 2006/07/19 09:00 [pubmed] PHST- 2006/08/02 09:00 [medline] PHST- 2006/07/19 09:00 [entrez] PST - ppublish SO - J Insur Med. 2006;38(2):126-35.